SEC Form 13F

Rangeley Capital, LLC 13F Holdings

Inspect Rangeley Capital, LLC's 2026-06-30 SEC 13F positions, public filing date, amendments and original receipt.

As of 2026-08-15T03:59:59.999Z

Report period
2026-06-30
Publicly available
2026-08-15
Reported value
$109,455,131
Positions
183

Read this manager's filing book

Step 1 of 3

Disclosed positions

Rangeley Capital, LLC: source evidence dated 2026-08-15T03:59:59.999Z.

Issuer
DRIVEN BRANDS HLDGS INC
Ticker
DRVN
Class
COM
Reported value
$7,224,349
Reported amount
518,246
Unit
SH
Option
None
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

What was reported for this quarter?

13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.

SEC 13F-HR: 0001892688-26-000133
What you should see

Open the effective filing receipt and inspect shares, value and any put/call classification separately.

Step 3 of 3

Browse institutional filings

Open the effective filing receipt and inspect shares, value and any put/call classification separately.

Browse institutional filings
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Disclosed positions

See the complete disclosed positions
DRIVEN BRANDS HLDGS INCDRVNCOM$7,224,349518,246SHNone
REVOLUTION MEDICINES INCRVMDW*W EXP 12/17/202$4,682,00025,000SHNone
PROTHENA CORP PLCPRTASHS$4,085,073417,270SHNone
SEAPORT ENTMT GROUP INCSEGCOMMON STOCK$4,083,552153,517SHNone
GRINDR INCGRNDCOM$3,161,400220,000SHNone
STAR HLDGSSTHOSHS BEN INT$2,961,845324,408SHNone
FULL HSE RESORTS INCFLLCOM$2,582,363925,578SHNone
ARBUTUS BIOPHARMA CORPABUSCOM$2,400,000500,000SHNone
TRIPADVISOR INCTRIPCOM$2,083,920152,000SHNone
ECHOSTAR CORPECHOCL A$1,849,68717,800SHNone
ABIVAX SAABVXSPONSORED ADS$1,732,38013,000SHNone
GREEN DOT CORPGDOTCL A$1,723,795127,594SHNone
DISTRIBUTION SOLUTIONS GRP IDSGRCOM$1,723,05063,000SHNone
THERAVANCE BIOPHARMA INCTBPHCOM$1,691,50099,500SHNone
RALLYBIO CORPRLYBCOM$1,677,600104,850SHNone
ORION PROPERTIES INCONLCOM$1,672,059578,567SHNone
MONRO INCMNROCOM$1,651,11596,500SHNone
REVOLUTION MEDICINES INCRVMDCOM$1,629,3368,700SHNone
BRIGHTHOUSE FINL INCBHFCOM$1,582,50025,000SHNone
JANUX THERAPEUTICS INCJANXCOM$1,504,94297,978SHNone
NOMAD FOODS LTDNOMDUSD ORD SHS$1,478,250135,000SHNone
ARVINAS INCARVNCOM$1,459,153175,590SHNone
DELEK US HLDGS INC NEWDKCOM$1,371,87027,000SHNone
WARNER BROS DISCOVERY INCWBDCOM SER A$1,359,66051,000SHNone
ZIM INTEGRATED SHIPPING SERVZIMSHS$1,352,00052,000SHNone
MOUNTAIN LAKE ACQUISIT CORPUnresolvedUSD CL A ORD SHS$1,268,965127,791SHNone
ENTRAVISION COMMUNICATIONS CEVCCL A$1,186,64091,000SHNone
RAPID7 INCRPDCOM$1,158,300143,000SHNone
BICYCLE THERAPEUTICS PLCBCYCSPONSORED ADS$1,074,840253,500SHNone
NET LEASE OFFICE PROPERTIESNLOPCOM$1,057,35095,000SHNone
KURA ONCOLOGY INCKURACOM$1,031,18094,000SHNone
WILLIS LEASE FIN CORPWLFCCOM$915,2004,000SHNone
WEN ACQUISITION CORPWENNCOM CL A$897,33388,113SHNone
DOMO INCDOMOCOM CL B$863,880276,000SHNone
META PLATFORMS INCMETACL A$844,9351,500SHNone
RAYONIER ADVANCED MATLS INCRYAMCOM$823,791104,808SHNone
IMMERSION CORPIMMRCOM$744,700110,000SHNone
FORWARD AIR CORPFWRDCOM$743,05055,000SHNone
INMODE LTDINMDSHS$731,00050,000SHNone
DOUBLEDOWN INTERACTIVE CO LTDDIADS$700,28061,000SHNone
CALUMET INCCLMTCOM$684,38019,000SHNone
XPONENTIAL FITNESS INCXPOFCOM CL A$674,59697,485SHNone
CHARTER COMMUNICATIONS INCCHTRCL A$639,9454,500SHNone
D. BORAL ARC ACQ I CORP.BCARSHS CL A$637,79561,150SHNone
AXIOM INTELLIGENCE AC CORP 1AXINORD SHS CL A$632,73661,193SHNone
ROMAN DBDR ACQUISITION CORPDRDBORD SHS CL A$632,10060,000SHNone
GROCERY OUTLET HLDG CORPGOCOM$628,74063,000SHNone
PHIBRO ANIMAL HEALTH CORPPAHCCL A COM$628,00020,000SHNone
COHEN CIRCLE ACQUISIT CORP ICCIISHS CL A$615,84660,200SHNone
YEXT INCYEXTCOM$608,632130,328SHNone

Largest 50 positions by reported value; the filing may contain more positions.

How amendments affect these holdings

This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 28 positions lack a resolved ticker and 7 positions are put or call entries.

A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.

Quarter end and public filing date

Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.